Frankfurt University Hospital

addFrankfurt am Main, Germany
( 8/10 from votes )
Prof. Dr. Peter Bader

Head of the Department

Prof. Dr. Peter Bader

Stem cell transplantation, immunology and intensive care medicine

The department of Stem cell transplantation, immunology, and intensive care medicine at the university hospital Frankfurt am Main focus on the treatment of children, adolescents, and young adults with malignant and non-malignant diseases.
The department under the guidance of Prof. Dr. med. Peter Bader put special focus on the implementation of haploidentical stem cell transplantation and treatment with chimeric antigen receptor (CAR) T cells for patients suffering from different types of leukemia.
The department also consists of an outpatient clinic for immunodeficiencies, where the doctor looks after patients with congenital and acquired immunodeficiencies.
The pediatric intensive care unit of the department not only treats the seriously ill children with internal diseases but also treats patients requiring intensive care from the surgical disciplines like pediatric surgery, accident surgery, neurosurgery, urology, cardiac and thoracic surgery, vascular surgery, orthopedics, ophthalmology, ear, nose and throat medicine, and oral and maxillofacial surgery.

The department of Stem cell transplantation, immunology, and intensive care medicine at the university hospital Frankfurt am Main is specialized in:

1) Stem cell transplantation in the following diseases:

  • Diseases of the blood:
    • Acute lymphoblastic leukemia (ALL)
    • Acute myeloid leukemia (AML)
    • Chronic myelogenous leukemia (CML)
    • Juvenile myelomonocytic leukemia (JMML)
    • Myelodysplastic syndrome (MDS)
  • Lymphomas
    • Hodgkin’s disease
    • Non-Hodgkin’s lymphoma
  • Solid tumors
    • Soft tissue sarcoma
    • Ewing’s sarcoma
    • Neuroblastoma
    • Hepatoblastoma
    • PNET
    • Synovial sarcoma
    • Nephroblastoma
    • Germ cell tumors

2) CAR-T cell therapy
3) CIK cell therapy
4) Mesenchymal stromal cells for the treatment of steroid-refractory acute GvHD